Beck–Fahrner syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Beck–Fahrner syndrome
File:Craniofacial features in Beck–Fahrner syndrome.png
Synonyms
Pronounce
Specialty	Medical genetics
Symptoms	Developmental delay, intellectual disability, distinctive facial features
Complications	N/A
Onset
Duration
Types
Causes	Genetic mutation in the TET3 gene
Risks
Diagnosis	Genetic testing, clinical evaluation
Differential diagnosis
Prevention
Treatment	Supportive care, individualized therapy
Medication
Prognosis	Varies
Frequency	Rare
Deaths

File:TET enzymes and 5hmC in epigenetic regulation of mammalian neurobiology.jpg

TET enzymes and 5hmC in epigenetic regulation of mammalian neurobiology

File:Beck–Fahrner syndrome or TET3 deficiency episignature.png

Beck–Fahrner syndrome or TET3 deficiency episignature

Beck-Fahrner Syndrome (BFS) is a rare genetic disorder characterized by a spectrum of developmental and physical anomalies. It is caused by mutations in the ZNF462 gene, which plays a crucial role in the regulation of gene expression during embryonic development. This syndrome was first described by Beck and Fahrner in the early 21st century, highlighting its recent discovery in the field of genetics.

Symptoms and Characteristics

Beck-Fahrner Syndrome presents a wide range of symptoms, which can vary significantly among affected individuals. Common characteristics include:

• Developmental Delays: Individuals with BFS often experience delays in reaching developmental milestones, such as walking and talking.
• Intellectual Disability: Mild to moderate intellectual disability is common among those diagnosed with BFS.
• Facial Dysmorphisms: Distinctive facial features may include a broad forehead, widely spaced eyes (hypertelorism), a small jaw (micrognathia), and low-set ears.
• Skeletal Anomalies: Skeletal issues, such as scoliosis or abnormalities in the fingers and toes, may be present.
• Growth Abnormalities: Affected individuals might exhibit growth abnormalities, including both growth retardation and overgrowth.

Genetics

Beck-Fahrner Syndrome is caused by mutations in the ZNF462 gene, which is located on chromosome 9. The ZNF462 gene encodes a zinc finger protein that is involved in the regulation of other genes, playing a critical role in early development. BFS is inherited in an autosomal dominant manner, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder. However, many cases result from new mutations in the gene and occur in people with no history of the disorder in their family.

Diagnosis

Diagnosis of Beck-Fahrner Syndrome is based on clinical evaluation and the identification of characteristic symptoms. Genetic testing can confirm the diagnosis by detecting mutations in the ZNF462 gene. Prenatal testing may be available for families with a known history of BFS.

Management and Treatment

There is no cure for Beck-Fahrner Syndrome, and treatment is symptomatic and supportive. Management strategies may include:

• Early Intervention Programs: To address developmental delays and intellectual disability.
• Therapeutic Services: Physical, occupational, and speech therapies can help improve motor skills and communication abilities.
• Medical Management: Treatment for skeletal anomalies, growth issues, and other medical concerns as needed.
• Educational Support: Special education programs and resources to support learning and development.

Prognosis

The prognosis for individuals with Beck-Fahrner Syndrome varies depending on the severity of symptoms and the effectiveness of management strategies. With appropriate support, many affected individuals can lead fulfilling lives.

See Also

• Genetic Disorder
• Intellectual Disability
• Developmental Delay
• Autosomal Dominant Inheritance